T1	PROC 112 139	TRATAMIENTO INMUNOMODULADOR
T2	DISO 212 235	Neumonía grave COVID-19
T3	DISO 285 308	Neumonía grave COVID-19
T4	PROC 854 857	AST
#1	AnnotatorNotes T4	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T5	PROC 546 570	medida con pulsioxímetro
T6	PROC 687 711	fracción de O2 inspirado
T7	DISO 381 403	Infiltrados pulmonares
#2	AnnotatorNotes T7	C0277877; Radiologic infiltrate of lung; Finding
T8	DISO 451 459	neumonía
#3	AnnotatorNotes T8	C0032285; Pneumonia; Disease or Syndrome
T9	PROC 573 580	Pa:FiO2
#4	AnnotatorNotes T9	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
T10	CHEM 613 615	O2
#5	AnnotatorNotes T10	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T11	PROC 635 637	Sa
T12	PROC 644 660	saturación de O2
#6	AnnotatorNotes T12	C0523807; Oxygen saturation measurement; Laboratory Procedure
T13	CHEM 699 701	O2
#7	AnnotatorNotes T13	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T14	PROC 814 823	protocolo
#8	AnnotatorNotes T14	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T15	CHEM 598 600	O2
#9	AnnotatorNotes T15	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T16	DISO 1050 1058	COVID-19
#10	AnnotatorNotes T16	C5203670; COVID19 (disease); Disease or Syndrome
T17	PROC 722 746	Consentimiento informado
#11	AnnotatorNotes T17	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T18	PROC 925 936	Neutrófilos
#12	AnnotatorNotes T18	C0200633; Neutrophil count; Laboratory Procedure
T19	ANAT 943 947	cell
T20	PROC 956 965	Plaquetas
#13	AnnotatorNotes T20	C0032181; Platelet Count measurement; Laboratory Procedure
T21	ANAT 975 979	cell
T22	DISO 988 994	Sepsis
#14	AnnotatorNotes T22	C0243026; Sepsis; Disease or Syndrome
T23	DISO 997 1005	neumonía
#15	AnnotatorNotes T23	C0032285; Pneumonia; Disease or Syndrome
T24	PROC 638 642	FiO2
#16	AnnotatorNotes T24	C1512797; Inspired Oxygen Fraction Test; Diagnostic Procedure
T25	DISO 1076 1088	comorbilidad
#17	AnnotatorNotes T25	C1275743; Co-morbid conditions; Finding
T26	DISO 1147 1161	Diverticulitis
#18	AnnotatorNotes T26	C0012813; Diverticulitis; Disease or Syndrome | C0349774; Diverticulitis of gastrointestinal tract; Disease or Syndrome
T27	DISO 1175 1197	perforación intestinal
#19	AnnotatorNotes T27	C0021845; Intestinal Perforation; Disease or Syndrome
T28	DISO 1201 1218	Infección cutánea
T29	DISO 1233 1244	piodermitis
#20	AnnotatorNotes T29	C0034212; Pyoderma; Disease or Syndrome
T30	PROC 1291 1318	tratamiento inmunomodulador
T31	PROC 46 107	ENSAYO CLÍNICO ALEATORIZADO, CONTROLADO, ABIERTO, UNICÉNTRICO
T32	ANAT 326 345	Frotis nasofaríngeo
T33	PROC 350 353	PCR
#21	AnnotatorNotes T33	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T34	PROC 408 417	Rx simple
#22	AnnotatorNotes T34	C1306645; Plain x-ray; Diagnostic Procedure
T35	ANAT 393 403	pulmonares
#23	AnnotatorNotes T35	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T36	DISO 165 188	NEUMONIA GRAVE COVID 19
T37	CHEM 658 660	O2
#24	AnnotatorNotes T37	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T38	PROC 582 625	presión parcial O2/fracción de O2 inspirado
T39	PROC 858 861	ALT
#25	AnnotatorNotes T39	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T40	ANAT 1187 1197	intestinal
#26	AnnotatorNotes T40	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T41	ANAT 1211 1218	cutánea
#27	AnnotatorNotes T41	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T42	CHEM 517 524	oxígeno
#28	AnnotatorNotes T42	C0030054; oxygen; Biologically Active Substance · Element, Ion, or Isotope · Pharmacologic Substance
T43	PROC 503 524	Saturación de oxígeno
#29	AnnotatorNotes T43	C0523807; Oxygen saturation measurement; Laboratory Procedure
T44	PROC 661 685	medida con pulsioxímetro
T45	Date 13 17	2020
T46	LIVB 143 160	PACIENTES ADULTOS
#30	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group + C0001675; Adult; Age Group
T48	Age 270 280	18-80 años
T49	LIVB 368 378	SARS-CoV-2
#31	AnnotatorNotes T49	C5203676; SARS-CoV-2; Virus
T51	DEVI 557 570	pulsioxímetro
#32	AnnotatorNotes T51	C0182109; Pulse oximeter; Medical Device
T54	Neg_cue 1042 1044	no
T58	LIVB 1028 1037	patógenos
#33	AnnotatorNotes T58	C0450254; Pathogenic organism; Organism
T47	Date 1219 1227	en curso
T50	DEVI 672 685	pulsioxímetro
#34	AnnotatorNotes T50	C0182109; Pulse oximeter; Medical Device
A1	Population_data T46 Age
A2	Assertion T16 Negated
A3	Assertion T30 Contraindicated
#35	AnnotatorNotes T1	C1963758; Immunomodulation; Therapeutic or Preventive Procedure
#36	AnnotatorNotes T36	C5400377; COVID-19 pneumonia aggravated; Disease or Syndrome 
#37	AnnotatorNotes T2	C5400377; COVID-19 pneumonia aggravated; Disease or Syndrome 
#38	AnnotatorNotes T3	C5400377; COVID-19 pneumonia aggravated; Disease or Syndrome 
#39	AnnotatorNotes T32	C0444192; Nasopharyngeal swab (specimen); Body Substance 
#40	AnnotatorNotes T5	C0034108; Oximetry, Pulse; Diagnostic Procedure
#41	AnnotatorNotes T19	C0007634; Cells; Cell | C1269647; Entire cell; Cell
#42	AnnotatorNotes T21	C0007634; Cells; Cell | C1269647; Entire cell; Cell
#43	AnnotatorNotes T28	C0037278; Skin Diseases, Infectious; Disease or Syndrome 
#44	AnnotatorNotes T30	C1963758; Immunomodulation; Therapeutic or Preventive Procedure
R1	Experiences Arg1:T46 Arg2:T36	
R4	Experiences Arg1:T46 Arg2:T1	
R6	Location_of Arg1:T32 Arg2:T33	
T56	Result_or_Value 354 362	positiva
R7	Has_Result_or_Value Arg1:T33 Arg2:T56	
R8	Location_of Arg1:T35 Arg2:T7	
R9	Overlap Arg1:T7 Arg2:T8	
T57	Quantifier_or_Qualifier 525 538	aire ambiente
R10	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T57	
T59	Result_or_Value 539 545	<= 94%
R11	Used_for Arg1:T51 Arg2:T5	
R12	Has_Result_or_Value Arg1:T43 Arg2:T59	
T60	Result_or_Value 627 632	<=300
R13	Has_Result_or_Value Arg1:T38 Arg2:T60	
#45	AnnotatorNotes T38	C3897988; Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement; Laboratory Procedure
R14	Has_Result_or_Value Arg1:T9 Arg2:T60	
#46	AnnotatorNotes T6	C1512797; Inspired Oxygen Fraction Test; Diagnostic Procedure
T61	Result_or_Value 713 718	<=350
R15	Has_Result_or_Value Arg1:T6 Arg2:T61	
R16	Has_Result_or_Value Arg1:T12 Arg2:T61	
R17	Has_Result_or_Value Arg1:T24 Arg2:T61	
R18	Has_Result_or_Value Arg1:T11 Arg2:T61	
#47	AnnotatorNotes T11	C0523807; Oxygen saturation measurement; Laboratory Procedure
R19	Used_for Arg1:T50 Arg2:T44	
T62	Result_or_Value 866 920	valores superiores a 5 veces los niveles de normalidad
R20	Has_Result_or_Value Arg1:T39 Arg2:T62	
R21	Has_Result_or_Value Arg1:T4 Arg2:T62	
T63	Result_or_Value 937 951	< 500 cell/mmc
R22	Has_Result_or_Value Arg1:T18 Arg2:T63	
T64	Result_or_Value 966 983	< 50.000 cell/mmc
R23	Has_Result_or_Value Arg1:T20 Arg2:T64	
R24	Causes Arg1:T58 Arg2:T23	
R25	Causes Arg1:T58 Arg2:T22	
R26	Negation Arg1:T54 Arg2:T16	
T65	Observation 1129 1143	mal pronostico
#48	AnnotatorNotes T65	C0278252; Prognosis bad; Finding
R27	Before Arg1:T25 Arg2:T65	
T66	Spec_cue 1093 1098	puede
A4	Assertion T65 Speculated
R28	Speculation Arg1:T66 Arg2:T65	
T67	Quantifier_or_Qualifier 1162 1172	complicada
R29	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T67	
R30	Location_of Arg1:T40 Arg2:T27	
R31	Overlap Arg1:T28 Arg2:T47	
R32	Location_of Arg1:T41 Arg2:T28	
R33	Overlap Arg1:T29 Arg2:T47	
#49	AnnotatorNotes T56	C1446409; Positive; Finding
R5	Overlap Arg1:T43 Arg2:T5	
R34	Overlap Arg1:T11 Arg2:T24	
R35	Overlap Arg1:T11 Arg2:T44	
R36	Overlap Arg1:T12 Arg2:T44	
R37	Overlap Arg1:T12 Arg2:T6	
R38	Location_of Arg1:T41 Arg2:T29	
R2	Causes Arg1:T49 Arg2:T56	
#50	AnnotatorNotes T67	C0231242; Complicated; Functional Concept
#51	AnnotatorNotes T47	C0521116; Current (present time); Temporal Concept
#52	AnnotatorNotes T44	C0034108; Oximetry, Pulse; Diagnostic Procedure
A5	Experiencer T46 Patient
